|
Promus Ventures Community,
Los Altos-based Gauss Surgical has announced their $12.6 million Series B round financing, and Promus Ventures participated in the round. As part of this Series B round, Mike Collett will join the Board of Directors.
Promus Ventures previously led Gauss’ $12 million Series A round financing, and also participated in the company’s earlier seed round.
Providence Ventures led this new Series B round, and other investors included Jump Capital, Summation Health Ventures, LifeForce Ventures and the Stanford-StartX Fund.
Gauss’ FDA-cleared Triton System is a tablet-based vision platform that accurately estimates blood loss in the operating room. Scans taken during medical procedures of surgical sponges and blood-bearing canisters are then processed real-time by Triton's cloud-based algorithms, helping surgeons make better blood loss assessments.
Thanks for your support!
The Promus Ventures Team
|
|
|
|
